About the AI in Personalized Cancer Therapies Session
AI is revolutionizing personalized cancer treatments by analyzing a patient’s genetic, molecular, and clinical data to create highly tailored therapies. With machine learning algorithms, AI can identify specific mutations in a patient’s tumor and predict which therapies will be most effective. This ensures that patients receive treatments designed to target the unique characteristics of their cancer, enhancing efficacy and minimizing unnecessary side effects. By moving away from a one-size-fits-all approach, AI allows for precision medicine, where therapies are personalized, not only improving treatment outcomes but also significantly boosting survival rates and patient quality of life.
Topics Covered in AI in Personalized Cancer Therapies
Treatment Response Prediction
Mutation Prioritization
Clinical Decision Support
Dose Personalization
Patient Digital Twins
Multi-Omic Data Fusion
Related Scientific Sessions at CIOC 2027
Why Attend the AI in Personalized Cancer Therapies Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original AI in Personalized Cancer Therapies work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping AI in Personalized Cancer Therapies research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the AI in Personalized Cancer Therapies track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
AI in Personalized Cancer Therapies Conference 2027 — FAQs
What is the AI in Personalized Cancer Therapies track at CIOC 2027?
The AI in Personalized Cancer Therapies track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in AI in Personalized Cancer Therapies. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the AI in Personalized Cancer Therapies sessions?
Cancer researchers and clinicians, educators and students with an interest in AI in Personalized Cancer Therapies are all welcome — whether presenting or attending.
Can I present my research in the AI in Personalized Cancer Therapies track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for AI in Personalized Cancer Therapies sessions?
Yes. CIOC 2027 is a hybrid conference — attend the AI in Personalized Cancer Therapies track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.